Artelo Biosciences enters $20M common stock purchase agreement with Lincoln Park Capital

ARTELO BIOSCIENCES, INC.

Company may sell up to $20M of common stock over 36 months at discounts of 3-5% to market price.
Lincoln Park received 292,968 commitment shares as consideration for entering the agreement.
Proceeds from any sales will be used for working capital and general corporate purposes; company has no obligation to sell.
Regular purchases limited to 200,000 shares per day, increased if stock price exceeds $0.50 or $0.75, max $1M per purchase.
Accelerated purchases allowed at 95% of closing or VWAP, with additional accelerated purchases possible on same day.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.